$ACT Headlines Actavis continues pharmaceuticals
Post# of 88930
Posted On: 01/28/2014 11:56:03 AM
$ACT Headlines
Actavis continues pharmaceuticals dominance 11:33 a.m. Jan. 16, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
BlackBerry gains on Facebook talk; Apple red 3:00 p.m. Oct. 29, 2013 - Sue Chang
FDA recommends new limits on pain drugs 10:25 p.m. Oct. 24, 2013 - Thomas M. Burton
Large investors refuse to sell this market 11:05 a.m. Oct. 1, 2013 - The Trading Deck
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey
James Dinan's top stock picks 9:11 a.m. Aug. 21, 2013 - Insider Monkey
Major U.S. benchmarks take technically shaky turn 11:18 a.m. Aug. 15, 2013 - Michael Ashbaugh
Dow holds major support, Nasdaq presses new highs 9:39 a.m. July 29, 2013 - Michael Ashbaugh
Perrigo to buy biotech Elan in $8.6 billion deal 3:51 a.m. July 29, 2013 - Jonathan D. Rockoff
Actavis, Warner shares climb as investors anticipate pending merger 2:07 p.m. July 26, 2013 - Russ Britt
Actavis loss widens on impairment charge 6:58 a.m. July 25, 2013 - MarketWatch.com
Charting a slow-motion rally to record territory 11:06 a.m. July 23, 2013 - Michael Ashbaugh
Charting a slow-motion rally to record territory 10:50 a.m. July 23, 2013 - Michael Ashbaugh
Hedge fund conference picks: winners and losers 6:17 p.m. July 16, 2013 - William L. Watts
Supreme Court satisfies few with ruling on generic drug settlements 4:30 p.m. June 18, 2013 - Russ Britt
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog 6:50 p.m. Jan. 27, 2014 - Zacks.com
Teva Falls on Negative CHMP Opinion - Analyst Blog 5:20 p.m. Jan. 27, 2014 - Zacks.com
Will Pfizer (PFE) Miss This Earnings Season? - Analyst Blog 4:50 p.m. Jan. 27, 2014 - Zacks.com
Allergan Slips on Restasis Challenge - Analyst Blog 1:50 p.m. Jan. 23, 2014 - Zacks.com
Pharma Stocks Like Actavis Continue To Dominate At The Start Of 2014 6:40 a.m. Jan. 23, 2014 - Seeking Alpha
Teva to Acquire NuPathe - Analyst Blog 4:58 p.m. Jan. 22, 2014 - Zacks.com
Narrower-than-Expected Loss at Ironwood, Shares Up - Analyst Blog 3:31 p.m. Jan. 22, 2014 - Zacks.com
Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape 8:42 a.m. Jan. 22, 2014 - Zacks.com
More U.S. Companies Realize China Isn’t Worth the Trouble 4:27 a.m. Jan. 22, 2014 - InvestorPlace.com
Mallinckrodt Up on FDA Approval - Analyst Blog 12:10 p.m. Jan. 21, 2014 - Zacks.com
Will Cubist Pharma (CBST) Miss Earnings? - Analyst Blog 9:40 a.m. Jan. 21, 2014 - Zacks.com
Actavis Joins the Divestment Bandwagon - Analyst Blog 5:55 p.m. Jan. 20, 2014 - Zacks.com
Will Forest Labs (FRX) Beat Earnings Again? - Analyst Blog 11:10 a.m. Jan. 20, 2014 - Zacks.com
Actavis sells generic-pharma ops in seven European markets 2:57 a.m. Jan. 19, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Actavis Announces Agreement with Aurobindo Pharma to Divest Commercial Operations in Seven Western European Countries 3:33 p.m. Jan. 18, 2014 - benzinga.com
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily
Actavis Leads the Way 10:21 a.m. Jan. 17, 2014 - TheStreet.com
BioLineRx Progresses with BL-8040 - Analyst Blog 5:10 p.m. Jan. 16, 2014 - Zacks.com
Actavis to exit China, Bisaro says too much trouble for too little profit 11:03 a.m. Jan. 16, 2014 - Seeking Alpha
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF
Pharma Industry Technical Data: Zoetis, Avanir Pharma, Actavis, and Salix Pharma 7:30 a.m. Jan. 16, 2014 - PR Newswire - PRF
Actavis Announces Preliminary Financial Performance for FY 2013 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units 7:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Actavis' Generic Version of Micardis® Receives FDA Approval 4:57 p.m. Jan. 8, 2014 - PR Newswire
Actavis to Host 2014 Investor Meeting January 31 in New York 4:25 p.m. Jan. 6, 2014 - PR Newswire
Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana 8:00 a.m. Jan. 6, 2014 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
Actavis Receives Complete Response Letter from FDA For Progestin-Only Patch 8:00 a.m. Dec. 24, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
Actavis to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:25 a.m. Dec. 20, 2013 - PR Newswire
Vensun Pharmaceuticals, Inc. Completes Series B Financing 9:35 a.m. Dec. 19, 2013 - BusinessWire
Zimmer Holdings Names Paul Bisaro to Board of Directors 5:00 p.m. Dec. 16, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation 8:00 a.m. Dec. 11, 2013 - PR Newswire
Actavis continues pharmaceuticals dominance 11:33 a.m. Jan. 16, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
BlackBerry gains on Facebook talk; Apple red 3:00 p.m. Oct. 29, 2013 - Sue Chang
FDA recommends new limits on pain drugs 10:25 p.m. Oct. 24, 2013 - Thomas M. Burton
Large investors refuse to sell this market 11:05 a.m. Oct. 1, 2013 - The Trading Deck
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
10 popular health-care stocks among hedge funds 11:34 a.m. Sept. 4, 2013 - Insider Monkey
James Dinan's top stock picks 9:11 a.m. Aug. 21, 2013 - Insider Monkey
Major U.S. benchmarks take technically shaky turn 11:18 a.m. Aug. 15, 2013 - Michael Ashbaugh
Dow holds major support, Nasdaq presses new highs 9:39 a.m. July 29, 2013 - Michael Ashbaugh
Perrigo to buy biotech Elan in $8.6 billion deal 3:51 a.m. July 29, 2013 - Jonathan D. Rockoff
Actavis, Warner shares climb as investors anticipate pending merger 2:07 p.m. July 26, 2013 - Russ Britt
Actavis loss widens on impairment charge 6:58 a.m. July 25, 2013 - MarketWatch.com
Charting a slow-motion rally to record territory 11:06 a.m. July 23, 2013 - Michael Ashbaugh
Charting a slow-motion rally to record territory 10:50 a.m. July 23, 2013 - Michael Ashbaugh
Hedge fund conference picks: winners and losers 6:17 p.m. July 16, 2013 - William L. Watts
Supreme Court satisfies few with ruling on generic drug settlements 4:30 p.m. June 18, 2013 - Russ Britt
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
U.S. stock benchmarks rally from obvious support 9:51 a.m. June 10, 2013 - Michael Ashbaugh
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog 6:50 p.m. Jan. 27, 2014 - Zacks.com
Teva Falls on Negative CHMP Opinion - Analyst Blog 5:20 p.m. Jan. 27, 2014 - Zacks.com
Will Pfizer (PFE) Miss This Earnings Season? - Analyst Blog 4:50 p.m. Jan. 27, 2014 - Zacks.com
Allergan Slips on Restasis Challenge - Analyst Blog 1:50 p.m. Jan. 23, 2014 - Zacks.com
Pharma Stocks Like Actavis Continue To Dominate At The Start Of 2014 6:40 a.m. Jan. 23, 2014 - Seeking Alpha
Teva to Acquire NuPathe - Analyst Blog 4:58 p.m. Jan. 22, 2014 - Zacks.com
Narrower-than-Expected Loss at Ironwood, Shares Up - Analyst Blog 3:31 p.m. Jan. 22, 2014 - Zacks.com
Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape 8:42 a.m. Jan. 22, 2014 - Zacks.com
More U.S. Companies Realize China Isn’t Worth the Trouble 4:27 a.m. Jan. 22, 2014 - InvestorPlace.com
Mallinckrodt Up on FDA Approval - Analyst Blog 12:10 p.m. Jan. 21, 2014 - Zacks.com
Will Cubist Pharma (CBST) Miss Earnings? - Analyst Blog 9:40 a.m. Jan. 21, 2014 - Zacks.com
Actavis Joins the Divestment Bandwagon - Analyst Blog 5:55 p.m. Jan. 20, 2014 - Zacks.com
Will Forest Labs (FRX) Beat Earnings Again? - Analyst Blog 11:10 a.m. Jan. 20, 2014 - Zacks.com
Actavis sells generic-pharma ops in seven European markets 2:57 a.m. Jan. 19, 2014 - Seeking Alpha
China Biotech In Review: Thermo Fisher Approved For Acquisition Of Life Technologies 2:07 a.m. Jan. 19, 2014 - Seeking Alpha
Actavis Announces Agreement with Aurobindo Pharma to Divest Commercial Operations in Seven Western European Countries 3:33 p.m. Jan. 18, 2014 - benzinga.com
Several IBD 50 Medical Companies Seen Posting Strong Q4 Profit Gains 5:16 p.m. Jan. 17, 2014 - Investors Business Daily
Actavis Leads the Way 10:21 a.m. Jan. 17, 2014 - TheStreet.com
BioLineRx Progresses with BL-8040 - Analyst Blog 5:10 p.m. Jan. 16, 2014 - Zacks.com
Actavis to exit China, Bisaro says too much trouble for too little profit 11:03 a.m. Jan. 16, 2014 - Seeking Alpha
Actavis Announces Agreement with Zhejiang Chiral Medicine Chemicals Co., Ltd to Divest Actavis Foshan, China 4:05 p.m. Jan. 24, 2014 - PR Newswire - PRF
Actavis Comments on Notification to Allergan, Inc. of Submission of Application for Restasis® 12:41 p.m. Jan. 22, 2014 - PR Newswire - PRF
Actavis Announces Agreement with Aurobindo Pharma Limited to Divest Commercial Operations in Seven Western European Countries 9:45 p.m. Jan. 17, 2014 - PR Newswire - PRF
Actavis Confirms Court Upholds Lo Loestrin® Fe Patent 5:42 p.m. Jan. 17, 2014 - PR Newswire - PRF
Pharma Industry Technical Data: Zoetis, Avanir Pharma, Actavis, and Salix Pharma 7:30 a.m. Jan. 16, 2014 - PR Newswire - PRF
Actavis Announces Preliminary Financial Performance for FY 2013 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units 7:30 a.m. Jan. 14, 2014 - PR Newswire - PRF
Upcoming Earnings Conference Calls, FDA Approvals, and Share Price Updates - Research Report on Actavis, ResMed, West Pharmaceutical, Sirona Dental Systems, and Theravance 8:00 a.m. Jan. 13, 2014 - PR Newswire - PRF
Actavis' Generic Version of Micardis® Receives FDA Approval 4:57 p.m. Jan. 8, 2014 - PR Newswire
Actavis to Host 2014 Investor Meeting January 31 in New York 4:25 p.m. Jan. 6, 2014 - PR Newswire
Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana 8:00 a.m. Jan. 6, 2014 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
Actavis Receives Complete Response Letter from FDA For Progestin-Only Patch 8:00 a.m. Dec. 24, 2013 - PR Newswire
Commercial Agreements, Stock Price Updates, Regulatory Approvals, Patent Litigation Settlements, and New Health Plan Strategies - Research Report on Biogen, Express Scripts, GSK, Actavis, and Aetna 8:00 a.m. Dec. 23, 2013 - PR Newswire
Actavis to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:25 a.m. Dec. 20, 2013 - PR Newswire
Vensun Pharmaceuticals, Inc. Completes Series B Financing 9:35 a.m. Dec. 19, 2013 - BusinessWire
Zimmer Holdings Names Paul Bisaro to Board of Directors 5:00 p.m. Dec. 16, 2013 - PR Newswire
Technical Research on Equities: Zoetis, Actavis, Avanir Pharma, and Salix Pharma 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
Actavis Announces Tentative Agreement Related to Asacol® HD Patent Challenge Litigation 8:00 a.m. Dec. 11, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼